Follow
Suresh K. Nagumalli
Suresh K. Nagumalli
NCTR, FDA
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
(−)-Oleocanthal combined with lapatinib treatment synergized against HER-2 positive breast cancer in vitro and in vivo
AB Siddique, HY Ebrahim, MR Akl, NM Ayoub, AA Goda, MM Mohyeldin, ...
Nutrients 11 (2), 412, 2019
302019
A rapid and highly sensitive UPLC-ESI-MS/MS method for the analysis of the fatty acid profile of edible vegetable oils
SK Nagumalli, CC Jacob, GG da Costa
Journal of Chromatography B 1161, 122415, 2020
112020
Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice
SK Nagumalli, RA Willett, A de Conti, VP Tryndyak, MI Avigan, ...
The Journal of nutritional biochemistry 109, 109108, 2022
32022
Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice
VP Tryndyak, RA Willett, SK Nagumalli, D Li, MI Avigan, FA Beland, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 324 (3 …, 2023
22023
1H-NMR-Based Chemometric Analysis of Echinacea Species to Predict Effectors of Myeloid Progenitor Stimulation
SK Nagumalli, JT Salley, JD Carstens
Analytica 5 (1), 28-53, 2024
12024
Proton NMR-Based Chemometric Analysis of Pharmacological and Toxicological Effects of Echinacea
SK Nagumalli
University of Louisiana at Monroe, 2018
12018
Assessment of clinical chemistry and hematological parameters in female Sprague-Dawley rats following a 7-day oral exposure to three different species of Echinacea
SK Nagumalli, JT Salley, JD Carstens
Journal of Environmental Science and Health, Part C, 1-18, 2024
2024
India
SK Nagumalli
Information Resources in Toxicology (Fifth Edition) 2, 211-246, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–8